- Home
- VNDA vs AEF Comparison
VNDA vs AEF Comparison
Compare VNDA & AEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- AEF
- Stock Information
- Founded
- VNDA 2002
- AEF 1989
- Country
- VNDA United States
- AEF United States
- Employees
- VNDA N/A
- AEF N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- AEF Finance/Investors Services
- Sector
- VNDA Health Care
- AEF Finance
- Exchange
- VNDA Nasdaq
- AEF Nasdaq
- Market Cap
- VNDA 249.4M
- AEF 250.9M
- IPO Year
- VNDA 2006
- AEF N/A
- Fundamental
- Price
- VNDA $4.75
- AEF $6.12
- Analyst Decision
- VNDA Strong Buy
- AEF
- Analyst Count
- VNDA 2
- AEF 0
- Target Price
- VNDA $16.50
- AEF N/A
- AVG Volume (30 Days)
- VNDA 551.9K
- AEF 92.5K
- Earning Date
- VNDA 07-31-2025
- AEF 01-01-0001
- Dividend Yield
- VNDA N/A
- AEF 7.13%
- EPS Growth
- VNDA N/A
- AEF N/A
- EPS
- VNDA N/A
- AEF 0.57
- Revenue
- VNDA $203,467,000.00
- AEF N/A
- Revenue This Year
- VNDA $16.86
- AEF N/A
- Revenue Next Year
- VNDA $39.78
- AEF N/A
- P/E Ratio
- VNDA N/A
- AEF $8.86
- Revenue Growth
- VNDA 11.78
- AEF N/A
- 52 Week Low
- VNDA $3.81
- AEF $4.40
- 52 Week High
- VNDA $5.55
- AEF $5.53
- Technical
- Relative Strength Index (RSI)
- VNDA 60.39
- AEF 54.29
- Support Level
- VNDA $4.47
- AEF $6.00
- Resistance Level
- VNDA $4.88
- AEF $6.22
- Average True Range (ATR)
- VNDA 0.16
- AEF 0.08
- MACD
- VNDA 0.05
- AEF -0.01
- Stochastic Oscillator
- VNDA 82.43
- AEF 61.54
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, private equity, communication services, healthcare, real estate, and industrials.